Less Ads, More Data, More Tools Register for FREE

Pin to quick picksVolex Regulatory News (VLX)

Share Price Information for Volex (VLX)

Share Price is delayed by 15 minutes
Get Live Data
567.00    -20.00 (-3.41%)
Bid:
565.00
Ask:
567.00
Spread: 2.00 (0.354%)
Market Cap: £1.04b
VLX Live PriceLast checked at - London Stock Exchange

Intraday Volex Share Chart

Trading Update and Board Appointments

14 Dec 2012 07:00

RNS Number : 5167T
Volex PLC
14 December 2012
 



 

 

 

For Immediate Release 14 December 2012

Volex plc

 

Trading Update and Board Appointments

 

Volex plc ('Volex' or together with its subsidiaries, the 'Company'), the global provider of electrical, digital and optical connections, today announces an update on trading.

 

Current trading

 

Contrary to earlier expectations of growth in second half revenue, the Company has experienced a general softening of demand across all sectors as well as delays in specific project timelines, which does not include our largest customer. As a result, we anticipate our full year revenues for the year ending 31 March, 2013 will now be in the range of $470-$485 million. The full year normalised operating profit is now expected to be in the range of $11m to $14m.

 

Improvement plan

 

At the interim results the Board announced three key initiatives to improve profitability; namely a significant reduction in operating expenditures, improvements to our Consumer gross margins and the realisation of new revenue pipeline:

 

·; reductions in operating expenses actioned to date exceed the initial 10% target

·; underlying Consumer gross margin improvements are on track

·; revenue pipeline continues to grow, but conversion to revenues delayed

 

Given the reduced revenues, the Board has taken further decisive action and is:

 

·; widening the scope of the cost reduction initiatives

·; implementing programmes to better align the sales organisation with current and future customer needs

·; strengthening the senior sales leadership and

·; accelerating the Company's move to a higher margin product portfolio

 

Board appointments

 

Further to our announcement on the 10th December that Andrew Cherry will be leaving the Company, we are pleased to announce that Daniel Abrams will be joining the Company, as Group Finance Director and executive director of the Board on 17 December 2012.

 

Daniel has over twenty years' experience in senior financial and operational roles, primarily in the manufacturing and technology industries. Most recently, he was Group Finance Director with Fiberweb plc, an international manufacturer of specialist non-woven fabric technology from February 2008 to April 2012. Prior to joining Fiberweb, Daniel held a number of executive roles including Finance Director of Xenova plc from 1997 to 2005. His other executive roles have included Vice President & CFO South Asia & Africa Division for PepsiCo and Head of Corporate Finance & Strategy for Diageo plc.

 

Furthermore, Karen Slatford, currently a non-executive director of the Company, will assume the role of Deputy Chairman. Karen has extensive sales and marketing experience, having been Vice President and General Manager Worldwide Sales & Marketing for Hewlett Packard. In this new role, she will work with the Executive team to optimise the sales function and to build enhanced customer relationships.

There are no further disclosures pursuant to paragraphs 9.6.13(1) to 9.6.13(6) of the Listing Rules in relation to the appointment above.

 

For further information please contact:

Volex plc

Ray Walsh, Group Chief Executive +44 20 3370 8830

Andrew Cherry, Group Finance Director

Buchanan

Charles Ryland / Jeremy Garcia / Sophie McNulty +44 20 7466 5000

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
MSCBCBDDRXBBGDX
Date   Source Headline
26th May 20263:00 pmRNSNotice of Results
15th May 20267:45 amRNSHolding(s) in Company
11th May 20267:00 amRNSHolding(s) in Company
30th Apr 20263:07 pmRNSHolding(s) in Company
22nd Apr 20267:00 amRNSCapital Markets Event
7th Apr 20267:00 amRNSLaunch of £40 million Share Buyback Programme
7th Apr 20267:00 amRNSUpdate on Move to the Main Market
26th Mar 20265:30 pmRNSHolding(s) in Company
25th Mar 20267:00 amRNSTrading update and Notice of Capital Markets Event
20th Mar 20262:00 pmRNSDirector/PDMR Shareholding
10th Feb 20267:45 amRNSHolding(s) in Company
2nd Feb 20264:45 pmRNSDirector/PDMR Shareholding
30th Jan 20264:30 pmRNSDirector/PDMR Shareholding
21st Jan 20267:00 amRNSTrading Update
12th Jan 20265:30 pmRNSDirector/PDMR Shareholding
8th Jan 20262:00 pmRNSDirector/PDMR Shareholding
5th Jan 20263:00 pmRNSIssue of Equity and Total Voting Rights
15th Dec 20257:00 amRNSDirector/PDMR Shareholding
11th Dec 20255:55 pmRNSDirector/PDMR Shareholding
4th Dec 202511:30 amRNSScrip Reference Price
12th Nov 20257:00 amRNSAppointment of Non-Executive Chair and CEO
12th Nov 20257:00 amRNSHalf-year Report
20th Oct 20257:00 amRNSNotice of Results
16th Oct 20257:00 amRNSHalf Year Trading Update
29th Sep 20251:25 pmRNSHolding(s) in Company
18th Sep 20257:00 amRNSHolding(s) in Company
15th Sep 202511:30 amRNSDirector/PDMR Shareholding
15th Sep 202510:15 amRNSHolding(s) in Company
5th Sep 20259:00 amRNSDirector/PDMR Shareholding
1st Sep 20251:00 pmRNSIssue of Equity and Total Voting Rights
7th Aug 20254:35 pmRNSResult of AGM
7th Aug 202512:30 pmRNSScrip Reference Price
7th Aug 20257:00 amRNSAGM Statement
4th Aug 20252:00 pmRNSHolding(s) in Company
7th Jul 20254:35 pmRNSPDMR / PCA Shareholding
4th Jul 202511:00 amRNSNotice of AGM and Publication of Annual Report
26th Jun 20257:00 amRNSPreliminary Group Results FY2025
2nd Jun 20257:00 amRNSNotice of Results and Investor Presentation
16th Apr 20252:00 pmRNSDirector/PDMR Shareholding
16th Apr 20251:00 pmRNSDirector/PDMR Shareholding
10th Apr 20256:00 pmRNSDirector/PDMR Shareholding
7th Apr 20257:00 amRNSFull Year Trading Update
19th Mar 20253:30 pmRNSDirector/PDMR Shareholding
13th Mar 20255:45 pmRNSHolding(s) in Company
27th Jan 20257:00 amRNSChange of Adviser
27th Jan 20257:00 amRNSTrading Update
16th Jan 20251:15 pmRNSDirector/PDMR Shareholding
16th Jan 20251:15 pmRNSDirector/PDMR Shareholding
3rd Jan 20257:00 amRNSDeferred Consideration for Acquisition
19th Dec 20247:00 amRNSForm 8.3 - Volex PLC

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.